Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity

Peptide MHC class II–based (pMHCII-based) nanomedicines trigger the formation of multicellular regulatory networks by reprogramming autoantigen-experienced CD4(+) T cells into autoimmune disease–suppressing T regulatory type 1 (TR1) cells. We have shown that pMHCII-based nanomedicines displaying liv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Umeshappa, Channakeshava Sokke, Mbongue, Jacques, Singha, Santiswarup, Mohapatra, Saswat, Yamanouchi, Jun, Lee, Justin A., Nanjundappa, Roopa Hebbandi, Shao, Kun, Christen, Urs, Yang, Yang, Ellestad, Kristofor K., Santamaria, Pere
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Concise Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108901/
https://ncbi.nlm.nih.gov/pubmed/32125290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI130670
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados